Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
19 October 2006Website:
http://www.lemaitre.comNext earnings report:
27 February 2025Last dividends:
15 August 2024Next dividends:
21 November 2024Price
pre-market | 51 min agoAnalysts recommendations
Institutional Ownership
LMAT Latest News
LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and double-digit CAGR over the past five years are particularly appealing. With a high-margin, low-competition niche and accelerating geographic expansion, LeMaitre remains well-positioned for sustained growth.
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2024 Earnings Conference Call October 33, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Suraj Kalia - Oppenheimer Rick Wise - Stifel Brett Fishbin - KeyBanc Jason Wittes - Roth Danny Stauder - Citizens JMP Michael Petusky - Barrington Research Frank Takkinen - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Ross Osborn - Cantor Fritzgerald Operator Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call.
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.33 per share a year ago.
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance.
BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
LeMaitre (LMAT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.37 per share a year ago.
What type of business is LeMaitre Vascular?
LeMaitre Vascular, Inc. is a medical equipment manufacturing company in the United States. Its products are used by vascular surgeons and specialist physicians in invasive procedures. The company offers angioscopes, fiber-optic catheters used for viewing the lumen of blood vessels; embolic catheters for removing clots from arteries or veins; occlusion catheters that temporarily block blood flow; perfusion catheters for temporary blood and other fluid perfusion into the vascular system; and thrombectomy catheters equipped with a silicone balloon for removing clots in the venous system. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
What sector is LeMaitre Vascular in?
LeMaitre Vascular is in the Healthcare sector
What industry is LeMaitre Vascular in?
LeMaitre Vascular is in the Medical Instruments & Supplies industry
What country is LeMaitre Vascular from?
LeMaitre Vascular is headquartered in United States
When did LeMaitre Vascular go public?
LeMaitre Vascular initial public offering (IPO) was on 19 October 2006
What is LeMaitre Vascular website?
https://www.lemaitre.com
Is LeMaitre Vascular in the S&P 500?
No, LeMaitre Vascular is not included in the S&P 500 index
Is LeMaitre Vascular in the NASDAQ 100?
No, LeMaitre Vascular is not included in the NASDAQ 100 index
Is LeMaitre Vascular in the Dow Jones?
No, LeMaitre Vascular is not included in the Dow Jones index
When was LeMaitre Vascular the previous earnings report?
No data
When does LeMaitre Vascular earnings report?
The next expected earnings date for LeMaitre Vascular is 27 February 2025